We investigated the efficacy and safety of augmenting risperidone with fluvoxamine for the treatment of residual positive and negative symptoms in patients with chronic schizophrenia who had shown an incomplete response to risperidone. A total of 30 patients completed the open trial over a 12-week p
β¦ LIBER β¦
Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study
β Scribed by Henry Silver; Mina Kushnir; Alla Kaplan
- Book ID
- 118858075
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 331 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0006-3223
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Fluvoxamine augmentation in risperidone-
β
Hitoshi Takashi; Takio Sugita; Hisashi Higuchi; Tetsuo Shimizu
π
Article
π
2002
π
John Wiley and Sons
π
English
β 51 KB
π 1 views
Fluvoxamine augmentation in chronic schi
β
Henry Silver; Alla Kaplan; Mina Kushnir
π
Article
π
1995
π
John Wiley and Sons
π
English
β 355 KB
The effect of augmenting standard antipsychotic treatment with the specific serotonergic reuptake inhibitor (SSRI) fluvoxamine was examined in severely disabled chronic schizophrenic inpatients using an open, naturalistic protocol. Fluvoxamine in doses ranging from 25 to 200 mg was added to the ant
Amisulpride augmentation of clozapine: a
β
J. Munro; P. Matthiasson; S. Osborne; M. Travis; S. Purcell; A. M. Cobb; M. Laun
π
Article
π
2004
π
John Wiley and Sons
π
English
β 103 KB
Aripiprazole augmentation in the managem
β
Charalampos I. Mitsonis; Nikolaos P. Dimopoulos; Panagiotis A. Mitropoulos; Evan
π
Article
π
2007
π
Elsevier Science
π
English
β 173 KB
Risperidone versus clozapine in treatmen
β
Kristian Wahlbeck; Maxim Cheine; Katinka Tuisku; Antti Ahokas; Grigori Joffe; Ra
π
Article
π
2000
π
Elsevier Science
π
English
β 628 KB
P.2.033 Paroxetine augmentation of neuro
β
M.C. Jockers-ScherΓΌbl; F. Godemann; A. Pietzcker
π
Article
π
1997
π
Elsevier Science
π
English
β 143 KB